IMMUNOMIC THERAPEUTICS, INC.

Profile

Company Names

IMMUNOMIC THERAPEUTICS, INC.

Addresses

ATTN: ERIN DUFFY, 15010 BROSCHART RD., SUITE 250, ROCKVILLE, MD 20850

ATTN: C. ERIC WINZE, 15010 BROSCHART RD., SUITE 250, ROCKVILLE, MD 20850

ATTN: WILLIAM HEARL, 15010 BROSCHART RD., SUITE 250, ROCKVILLE, MD 20850

15010 BROSCHART RD., SUITE 250, ROCKVILLE, MD 20850

ATTN: WILLIAM HEARL, 1214 RESEARCH BLVD., SUITE 2016, HERSHEY, PA 17036

ATTN: WILLIAM HEARL, 313 W. LIBERTY ST., SUITE 343, LANCASTER, PA 17603

Phone Numbers

301-968-3509
301-728-0860
717-327-1919

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DELAWARE

Total Amount Raised:

$105,420,532.00

Number of Funding Rounds:

10
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
10
2025-05-29 
$6,500,000.00 
$16,000,000.00 
$9,500,000.00 
Equity 
9
2024-01-30 
$3,000,000.00 
$20,900,000.00 
$17,900,000.00 
Equity 
8
2020-02-18 
$77,728,230.00 
$77,728,230.00 
$0.00 
Equity 
7
2018-07-18 
$314,500.00 
$314,500.00 
$0.00 
Equity 
6
2017-02-28 
$4,629,750.00 
$10,000,000.00 
$5,370,250.00 
Debt 
5
2014-04-24 
$1,029,000.00 
$8,800,000.00 
$7,771,000.00 
Equity 
4
2013-12-28 
$6,755,052.00 
$8,800,000.00 
$2,044,948.00 
Equity 
3
2013-06-12 
$2,729,500.00 
$3,000,000.00 
$270,500.00 
Debt 
2
2012-10-31 
$1,117,500.00 
$1,300,000.00 
$182,500.00 
Debt 
1
2011-08-16 
$1,617,000.00 
$2,000,000.00 
$383,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
ROBERT 
 
AHLGREN 
DIRECTOR
KI-HONG 
 
AHN 
DIRECTOR
MATTHEW 
 
CHANG 
DIRECTOR
WILLIAM 
HEARL 
EXECUTIVE OFFICER, DIRECTOR, PROMOTER
WILLIAM 
G. 
HEARL 
EXECUTIVE OFFICER, DIRECTOR
TERI 
 
HEILAND 
EXECUTIVE OFFICER
TERI 
JONES 
HEILAND 
EXECUTIVE OFFICER
HYUK JOO 
 
JEE 
DIRECTOR
YANG GON 
 
JIN 
DIRECTOR
YANG-GON 
 
JIN 
DIRECTOR
ALEX 
KIM 
DIRECTOR
DONG-GUN 
 
KIM 
EXECUTIVE OFFICER, DIRECTOR
MICHAEL 
 
LACK 
DIRECTOR
MICHAEL 
D. 
LACK 
DIRECTOR
WINSTON 
LOWE 
EXECUTIVE OFFICER
BRUCE 
 
MACKLER 
EXECUTIVE OFFICER, DIRECTOR
BRUCE 
F. 
MACKLER 
EXECUTIVE OFFICER, DIRECTOR
WILLIAM 
BARRY 
MCDONALD 
DIRECTOR
ARLO 
 
MCGINN 
DIRECTOR
STEVE 
 
PARK 
DIRECTOR
BERNARD 
RUDNICK 
EXECUTIVE OFFICER, DIRECTOR
BERNARD 
C. 
RUDNICK 
EXECUTIVE OFFICER, DIRECTOR
LISA 
 
SALLEY 
EXECUTIVE OFFICER
RONALD 
 
THIBOUTOT 
DIRECTOR
RONALD 
P. 
THIBOUTOT 
DIRECTOR
C. 
ERIC 
WINZER 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
 
WISHART 
EXECUTIVE OFFICER, DIRECTOR
JAMES 
W. 
WISHART 
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2025-05-29 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-01-30 
D/A
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-02-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity, Debt 
2020-02-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-18 
D
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2017-02-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-12-28 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2013-12-28 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2014-04-24 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2013-06-12 
D/A
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-08-16 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Debt 
2012-10-31 
D
BIOTECHNOLOGY 
 
$1 - $1,000,000 
Equity 
2011-08-16 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
NEWPORT COAST SECURITIES INC.